Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$25,847,718
+$5,859,277 QoQ
Shares Held
21,550
-0.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.66%
of 13F equity value
Holder Rank
#782
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caldwell Trust Co holds $66,282,067 across 15 Drug Manufacturers - General names. LLY ranks #1 (39.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
21,550 | $25,847,718 | |
| 2 | JNJ |
Johnson & Johnson
|
56,485 | $14,345,495 | |
| 3 | AMGN |
Amgen Inc
|
26,584 | $9,626,598 | |
| 4 | ABBV |
AbbVie Inc.
|
27,070 | $6,811,894 | |
| 5 | MRK |
Merck & Co., Inc.
|
35,474 | $4,558,408 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
30,189 | $1,739,490 | |
| 7 | AZN |
Astrazeneca PLC
|
8,454 | $1,603,047 | |
| 8 | PFE |
Pfizer Inc
|
44,139 | $1,062,867 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,847,718 | 21,550 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $19,988,441 | 21,732 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $22,885,312 | 21,295 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $16,264,108 | 21,316 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $17,214,360 | 22,083 | Shares | Sole | 2025-09-22 | |
| 2025-03-31 | $17,950,327 | 21,734 | Shares | Sole | 2025-09-23 | |
| 2024-12-31 | $17,082,816 | 22,128 | Shares | Sole | 2025-09-24 | |
| 2024-09-30 | $19,583,703 | 22,105 | Shares | Sole | 2025-09-24 | |
| 2024-06-30 | $20,382,819 | 22,513 | Shares | Sole | 2025-09-24 | |
| 2024-03-31 | $17,771,718 | 22,844 | Shares | Sole | 2025-09-24 | |
| 2023-12-31 | $13,417,652 | 23,018 | Shares | Sole | 2025-10-01 | |
| 2023-09-30 | $12,288,459 | 22,878 | Shares | Sole | 2025-10-01 | |
| 2023-06-30 | $10,452,157 | 22,287 | Shares | Sole | 2025-10-01 | |
| 2023-03-31 | $7,776,401 | 22,644 | Shares | Sole | 2025-10-01 | |
| 2022-12-31 | $8,054,698 | 22,017 | Shares | Sole | 2025-10-01 | |
| 2022-09-30 | $7,360,415 | 22,763 | Shares | Sole | 2025-10-01 | |
| 2022-06-30 | $7,467,664 | 23,032 | Shares | Sole | 2025-10-02 | |
| 2022-03-31 | $6,611,996 | 23,089 | Shares | Sole | 2025-10-02 | |
| 2021-12-31 | $6,538,956 | 23,673 | Shares | Sole | 2025-10-02 | |
| 2021-09-30 | $5,614,515 | 24,300 | Shares | Sole | 2025-10-02 | |
| 2021-06-30 | $5,556,449 | 24,209 | Shares | Sole | 2025-10-02 | |
| 2021-03-31 | $4,588,486 | 24,561 | Shares | Sole | 2025-10-02 | |
| 2020-12-31 | $4,289,380 | 25,405 | Shares | Sole | 2025-10-02 | |
| 2020-09-30 | $3,810,330 | 25,742 | Shares | Sole | 2025-10-02 | |
| 2020-06-30 | $4,502,308 | 27,423 | Shares | Sole | 2025-10-02 | |
| 2020-03-31 | $3,885,131 | 28,007 | Shares | Sole | 2025-10-02 | |
| No filing history on record for this holder in this stock. | ||||||